UK markets closed

Arcutis Biotherapeutics, Inc. (ARQT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.20+0.08 (+0.88%)
At close: 04:00PM EDT
9.24 +0.04 (+0.43%)
After hours: 06:51PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
88,398
53,641
96,449
65,082
Other short-term investments
183,463
355,948
290,610
219,359
Total cash
271,861
409,589
387,059
284,441
Net receivables
25,807
8,458
0
-
Inventory
13,134
7,514
0
-
Other current assets
8,208
6,257
8,025
-
Total current assets
330,431
437,406
402,773
292,826
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
5,824
5,755
5,833
5,443
Accumulated depreciation
-1,924
-1,153
-532
-78
Net property, plant and equipment
3,900
4,602
5,301
5,365
Other long-term assets
596
78
78
78
Total non-current assets
10,934
11,868
5,379
5,443
Total assets
341,365
449,274
408,152
298,269
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
11,992
8,827
7,353
7,140
Accrued liabilities
19,069
14,323
16,410
11,028
Total current liabilities
46,668
37,807
33,326
22,602
Non-current liabilities
Long-term debt
201,799
197,769
72,350
-
Other long-term liabilities
849
-
25
82
Total non-current liabilities
206,030
201,886
77,149
5,046
Total liabilities
252,698
239,693
110,475
27,648
Stockholders' equity
Common stock
9
6
5
4
Retained earnings
-981,904
-719,764
-408,306
-201,950
Accumulated other comprehensive income
4
-1,086
-255
-2
Total stockholders' equity
88,667
209,581
297,677
270,621
Total liabilities and stockholders' equity
341,365
449,274
408,152
298,269